Abstract

A Targeted cDNA Microarray Identifies Cytoskeletal
Regulatory Proteins as Transcriptional Targets of Connective
Tissue Growth Factor (CTGF)/CCN2: Implications for
Diabetic Nephropathy
November 4, 2007
American Society of Nephrology (ASN) Renal Week 2007,
San Francisco, CA
Abstract SU-PO191
A Targeted cDNA Microarray Identifies Cytoskeletal
Regulatory Proteins as Transcriptional Targets of Connective
Tissue Growth Factor (CTGF)/CCN2: Implications for Diabetic Nephropathy.
M Browne1,
A Gaffney2,
C Godson2,
F Martin1,
J Crean1.
1 Diabetes Research Centre, UCD School of Biomolecular
and Biomedical Science, University College Dublin, Dublin Ireland;
2 Diabetes Research Centre, UCD School of Medicine and
Medical Science, University College Dublin, Ireland.
Abstract: Hyperglycaemia-induced increases in
glomerular mesangial extracellular matrix production and actin
cytoskeleton rearrangement are key pathological hallmarks of
diabetic nephropathy. Previously, we have described the use of a
Suppressive Subtractive Hybridisation (SSH) screen to identify
mRNA transcripts, which are differentially expressed in human
glomerular mesangial cells (HMCs) propagated in vitro under
conditions of either normal (5mM) or high (30mM) physiological
glucose. In this study, we have used focused cDNA microarray
technology to rapidly characterise the expression profile of
genes derived from this SSH in HMCs in response to a key,
profibrotic mediator of diabetic nephropathy, Connective
Tissue Growth Factor (CTGF/CCN2). From the SSH screen, 171
distinct clones were amplified via PCR and arrayed onto glass
slides. Analysis of the focused microarrays investigating
HMCs stimulated with CTGF revealed induction of 10 distinct
transcripts. CTGF was observed to induce the expression of the
actin/myosin-binding protein caldesmon, the myosin regulatory
chain and T-plastin alongside Arp-3 and fibronectin. In
addition, CTGF caused a down-regulation of tubulin alpha-3
and the F-actin capping protein. These data suggest that CTGF
activates an actin binding and regulatory protein cluster,
representing a previously undescribed genetic programme which
likely contributes to mesangial cell dysfunction in DN. When
HMCs were stimulated with CTGF and stained for tubulin and
F-actin, widespread microtubular and actin rearrangement was
apparent. This was accompanied by a polarized redistribution
of myosin, suggesting activation of the machinery of cell
migration. Redistribution of myosin was facilitated by
dephosphorylation of the myosin light and heavy chains in
response to CTGF, which was inhibited by the addition of the
myosin inhibitor 2,3 butanedionemonoxime. Increased expression
of Arp-3 in response to CTGF was associated with cdc42 dependent
PAK-1 phosphorylation. This data indicates that CCN2-mediated
actin rearrangement likely contributes to the pathophysiology
of the glomerular mesangium in diabetic nephropathy.
See also November 7, 2007 press
release